A 65-year-old man with a 20-year history of recurrent abdominal pain and vomiting was found to have eosinophilic enteritis affecting the muscularis layer of the distal ileum. Tests for malabsorption were negative. The IgE was raised but there was no evidence of an allergic predisposition. The symptoms, eosinophilia, and radiological abnormality responded to oral disodium cromoglycate.
Introduction
Eosinophilic gastroenteritis is an uncommon disease characterized by peripheral eosinophilia and eosinophilic infiltration of the gastrointestinal tract. The bone marrow shows a reactive eosinophilia and the symptoms and signs usually reflect the layer of bowel which is most severely affected. Predominant mucosal disease may be associated with malabsorption, muscle disease with obstructive symptoms and serosal disease with ascites. Laparotomy may be necessary to substantiate a diagnosis or to relieve obstruction. Corticosteroid therapy has been the most specific medication used while elimination diets have proved unsuccessful. This report is of a patient with clinical and histological evidence of eosinophilic enteritis involving the muscularis layer of bowel which responded to oral disodium cromoglycate. (Fig. 2) (Gregg and Utz, 1974; Rodriquez et al., 1973 ) but these cases may be part of the hypereosinophilic syndrome which can involve multiple organs other than the gastrointestinal tract (Chusid et al., 1975) .
There is conflicting evidence on the role of food allergy. One text includes abnormal symptoms or signs following ingestion of specific foods as a criterion for diagnosis (Greenberger and Gryboski, 1978) , while another concludes that hypersensitivity to food is not required in order to establish a diagnosis (Caldwell et al., 1978) .
Food allergy appears to be an unlikely mechanism in this patient in view of the negative history, normal mucosa, distal involvement of the gut, negative skin tests and negative RAST. It is difficult to attribute involvement of the deeper layers to contact with allergen in the absence of mucosal involvement.
Oral sodium cromoglycate has been used in the treatment of inflammatory bowel disease (Henderson and Hishon, 1978; Mani et al., 1976) , food allergy (Vaz, Tan and Gerrard, 1978) and, more recently, in gold-induced eosinophilic enterocolitis (Martin et al., 1981) . However, in the latter case improvement occurred with the withdrawal of the offending agent. In the only other report of response to sodium cromoglycate in eosinophilic enteritis (Heatley, Harris and Atkinson, 1980) , the patient developed polyarteritis nodosa and this may have been the disease from the outset. In both cases the patients had the mucosal form of the disorder which was secondary to another cause.
The response to the sodium cromoglycate in this patient was impressive in that there was a dramatic early fall in the long-standing eosinophilia. The patient gained weight, became asymptomatic and a repeat barium study was virtually normal. It is possible that the disodium cromoglycate was either absorbed through the gut wall to act on the abnormal muscularis section of bowel or, alternatively, acted on the mucosal surface preventing the release of mediators which act at the level of the muscularis mucosa.
This case also illustrates the difficulty encountered in diagnosing and monitoring patients whose sole involvement is limited to the muscularis layer. In this setting conventional endoscopic biopsies and a wide range of tests for malabsorption can be completely normal. Peripheral eosinophilia can be the only clue for diagnosis and therefore a simple differential white cell count is mandatory in all patients with 'obscure' abdominal complaints. Caldwell et al. (1978) failed to demonstrate any evidence for an IgE-mediated mechanism in the obstructive form of eosinophilic gastroenteritis. However, this case demonstrates that such mechanisms may indeed be operative in those with predominantly muscle layer involvement, and that disodium cromoglycate is of value in the IgEdependent group. This would be useful where the alternative therapy, corticosteroids, is inadvisable.
